References
- Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: A cross-sectional survey. Lancet. 2012;379:815–822.
- Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17:2937–2944.
- Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: A KDIGO Controversies Conference report. Kidney Int. 2011;80:17–28.
- Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289:2560–2572.
- Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26:S5–S20.
- Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1–253.
- Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–3421.
- Chinese Medical Association Endocrinology Branch. Chinese expert consensus hyperuricemia and gout treatment. Chin J Endocrinol Metab. 2013;29:913–920.
- Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1–12.
- Ansell D. Summary of findings in the 2006 UK Renal Registry Report (Chapter 1). Nephrol Dial Transpl. 2007;22:vii1–vii2.
- Hallan SI, Dahl K, Oien CM, et al. Screening strategies for chronic kidney disease in the general population: Follow-up of cross sectional health survey. BMJ. 2006;333:1047–1052.
- Chen N, Wang W, Huang Y, et al. Community-based Study on CKD Subjects and the associated risk factors. Nephrol Dial Transplant. 2009;24:2117–2123.
- Tozawa M, Iseki K, Iseki C, et al. Blood pressure predicts risk of developing end-stage renal disease in men and women. Hypertension. 2003;41:1341–1345.
- Drawz PE, Goswami P, Azem R, et al. A simple tool to predict end-stage renal disease within 1 year in elderly adults with advanced chronic kidney disease. J Am Geriatr Soc. 2013;61:763–768.
- Kovesdy CP, Bleyer AJ, Molnar MZ, et al. Blood pressure and mortality in U.S. veterans with chronic kidney disease: A cohort study. Ann Intern Med. 2013;159:233–242.
- Xuewang L, Hang L, Guojuan Z, et al. Development of the role of lipid abnormalities and kidney damage mechanism of statins in chronic kidney disease. J Appl Clin Hosp. 2008;5:1–5.
- Ruan XZ, Varghcsc Z, Moorhead JF. An update on the lipid nephrotoxicity hypothesis. Nat Rev Nephrol. 2009;5:713–721.
- Yaping F, Yan Y. Chronic kidney disease, dyslipidemia intervention process on chronic kidney disease. Chin J Nephrol. 2010;26:233–236.
- Staplin N, Haynes R, Herrington WG, et al. Smoking and adverse outcomes in patients with CKD: The Study of Heart and Renal Protection (SHARP). Am J Kidney Dis. 2016;68:371–380.
- Anan F, Masaki T, Takahashi N, et al. Smoking is associated with urinary albumin excretion: An evaluation of premenopausal patients with type 2 diabetes mellitus. Metab Clin Exp. 2007;56:179–184.
- Ejerblad E, Michael Fored C, Lindblad P, et al. Association between smoking and chronic renal failure in a nationwide population-based case-control study. J Am Soc Nephrol. 2004;15:2178–2185.
- Chonchol M, Shipak MG, Katz R, et al. Relationship of uric acid with progression of kidney disease. Am J Kidney Dis. 2007;50:239–247.
- Weiner DE, Tighiouart H, Elsayed EF, et al. Uric acid and incident kidney disease in the community. J Am Soc Nephrol. 2008;19:1204–1211.
- Chang HY, Tung CW, Lee PH, et al. Hyperuricemia as an independent risk factor of chronic kidney disease in middle-aged and elderly population. Am J Med Sci. 2010;339:509–515.